Melatonin – a go-to sleep aid for kids and adults alike in many households in America – continues to create media buzz, with conflicting messages that leave people uncertain about its safety. Some ...

It's the most widely studied sleep aid in children, but many parents still feel uncertain or even guilty about using it despite clear benefits.

Data show investigational atumelnant drove sustained androgen reductions while enabling lowering of glucocorticoid supplementation to ...

Crinetics Pharmaceuticals stock is a 'Buy' rating due to EU approval and strong initial U.S. uptake of Palsonify for ...

Debate continues over melatonin, a sleep aid widely used by both children and adults. Some claim it boosts immunity, while ...

H. Lundbeck A/S (Lundbeck) today announced preliminary Phase II Part A data from its ongoing study evaluating asedebart (Lu AG13909), an anti-adrenocorticotropic hormone (ACTH) monoclonal antibody, in ...

Patients who took widely available joint supplements marketed for arthritis relief ended up in clinics and emergency ...

Stacker compiled a list of facts you may not know about 25 major organs and what do for your body. Read on to see what you ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of its Phase 2 clinical study to assess the safety and tolerability of crinecerfont in children aged 3 months to under 4 ...

Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.

June 2026 Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours Based on ...